Neurocrine Biosciences Inc (NBIX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for NBIX. 13F holdings as of 2026-09-30.
In 13F filings for the quarter ended September 30, 2026, 633 institutions reported holding NBIX, with 79.4 million shares worth $11.3 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 14,856,103 | $2.1B | INCREASED |
| Vanguard | 10,438,588 | $1.5B | INCREASED |
| Dodge & Cox | 5,504,578 | $781M | DECREASED |
| JPMorgan Chase | 5,292,589 | $733M | DECREASED |
| State Street | 4,807,975 | $682M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Eiry Roberts (Chief Medical Officer) | AWARD | 1,506 | 2026-11-04 | |
| Eiry Roberts (Chief Medical Officer) | AWARD | 8,314 | $1M | 2026-11-04 |
| MORROW GEORGE J (Director) | EXERCISE | 7,200 | $386K | 2026-11-03 |
| MORROW GEORGE J (Director) | SELL | 1,300 | $219K | 2026-11-03 |
| MORROW GEORGE J (Director) | SELL | 1,500 | $252K | 2026-11-03 |
Full institutional holdings, insider history, and congressional trades for Neurocrine Biosciences Inc on SentiSense.